Business Standard

A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

AdvaMed disappointed with DoP's decision to include stents in DPCO

The US-based medical tech association AdvaMed feels that the move hinders the fundamental right of a

Rakesh Rao  |  Mumbai 

The Department of Pharmaceuticals (DoP) issued a notification yesterday putting bare metal stents (BMS) and drug eluting stents (DES), which include metallic DES & biodegradable stents, in schedule-I of the Drugs Prices COntrol Order, 2013 (DPCO). As a result of this notification, the National Pharmaceutical Pricing Authority (NPPA) will soon start the process of fixing ceiling prices for these stents. Expressing disappointment over the decision, Advanced Medical Technology Association (AdvaMed), the medical device trade association based in Washington (USA), said, “Putting ...

TO READ THE FULL STORY, SUBSCRIBE NOW AT JUST Rs 149 A MONTH

Key stories on business-standard.com are available to premium subscribers only.

LOGIN

EMAIL / USER NAME
PASSWORD
REMEMBER ME Forgot password?

Not a member yet ? Resister Now

Connect using any below

  • Don't lose the opportunity of saving $26.77 per month
  • Don't lose the opportunity of saving $26.77 per month
Total Amount
Rs. 0.00
To proceed, kindly select a subscription package

WHAT YOU GET

On Business Standard Digital

  • Access your subscription from anywhere. Be it your computer, tablet or smartphone using a browser or the App, Your Choice.
  • Access to exclusive content, features, opinions and comment, hand-picked by our editors, just for you.
  • Pick your 5 favourite companies. Get all the news upates at the end of each day through E-Mail.
  • Pick the industry that you want to track. And get a daily news letter specific to that industry. Cut out the clutter.
  • And stay on top of your investments. Track stock prices in your portfolio
  • Access 18 years of archival data

On Digital

  • Seamless access to WSJ.com with your Business Standard digital account.
  • Experience the best of the Journal's reporting, video and interactive features.
  • Read about the people and events shaping business, finance, technology, politics, technology and culture.
  • Stay informed with newsletters - an easy way to get WSJ content straight to your inbox - making life easier on your busiest days.
  • More business executives read the Journal globally than any other publication.
*Note :
Our Partners are proud to be associated with this initiative and will contribute Rs 100 x 6 months thereafter, standard rate of Rs 149 will be charged.
Offer valid for Indian residents only
Requires you to share personal information like PAN, Date of Birth, and Income.
*Annual saving on WSJ subscription price of US$ 347.88 (12 months @ US$ 28.99 per month)
* 1US$ = 67.50 INR.
*Please note that this offer is not valid if you are/were a registered/existing user on WSJ Digital
First Published: Thu, December 22 2016. 11:21 IST
RECOMMENDED FOR YOU

AdvaMed disappointed with DoP's decision to include stents in DPCO

The US-based medical tech association AdvaMed feels that the move hinders the fundamental right of a

The US-based medical tech association AdvaMed feels that the move hinders the fundamental right of a patient to have access to high-quality medical devices The Department of Pharmaceuticals (DoP) issued a notification yesterday putting bare metal stents (BMS) and drug eluting stents (DES), which include metallic DES & biodegradable stents, in schedule-I of the Drugs Prices COntrol Order, 2013 (DPCO). As a result of this notification, the National Pharmaceutical Pricing Authority (NPPA) will soon start the process of fixing ceiling prices for these stents. Expressing disappointment over the decision, Advanced Medical Technology Association (AdvaMed), the medical device trade association based in Washington (USA), said, “Putting ... image
Business Standard
177 22

AdvaMed disappointed with DoP's decision to include stents in DPCO

The US-based medical tech association AdvaMed feels that the move hinders the fundamental right of a

The Department of Pharmaceuticals (DoP) issued a notification yesterday putting bare metal stents (BMS) and drug eluting stents (DES), which include metallic DES & biodegradable stents, in schedule-I of the Drugs Prices COntrol Order, 2013 (DPCO). As a result of this notification, the National Pharmaceutical Pricing Authority (NPPA) will soon start the process of fixing ceiling prices for these stents. Expressing disappointment over the decision, Advanced Medical Technology Association (AdvaMed), the medical device trade association based in Washington (USA), said, “Putting ...

image
Business Standard
177 22